These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 25996601)

  • 1. Efficacy of Adjuvant 5-Fluorouracil Therapy for Patients with EMAST-Positive Stage II/III Colorectal Cancer.
    Hamaya Y; Guarinos C; Tseng-Rogenski SS; Iwaizumi M; Das R; Jover R; Castells A; Llor X; Andreu M; Carethers JM
    PLoS One; 2015; 10(5):e0127591. PubMed ID: 25996601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EMAST status as a beneficial predictor of fluorouracil-based adjuvant chemotherapy for Stage II/III colorectal cancer.
    Mohammadpour S; Goodarzi HR; Jafarinia M; Porhoseingholi MA; Nazemalhosseini-Mojarad E
    J Cell Physiol; 2020 Apr; 235(4):3604-3611. PubMed ID: 31549400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative stress induces nuclear-to-cytosol shift of hMSH3, a potential mechanism for EMAST in colorectal cancer cells.
    Tseng-Rogenski SS; Chung H; Wilk MB; Zhang S; Iwaizumi M; Carethers JM
    PLoS One; 2012; 7(11):e50616. PubMed ID: 23226332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined Microsatellite Instability and Elevated Microsatellite Alterations at Selected Tetranucleotide Repeats (EMAST) Might Be a More Promising Immune Biomarker in Colorectal Cancer.
    Chen MH; Chang SC; Lin PC; Yang SH; Lin CC; Lan YT; Lin HH; Lin CH; Lai JI; Liang WY; Lu ML; Yang MH; Chao Y
    Oncologist; 2019 Dec; 24(12):1534-1542. PubMed ID: 31292272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated Microsatellite Alterations at Selected Tetranucleotide Repeats (EMAST) and Microsatellite Instability in Patients with Colorectal Cancer and Its Clinical Features.
    Lee HS; Park KU; Kim DW; Lhn MH; Kim WH; Seo AN; Chang HE; Nam SK; Lee SY; Oh HK; Kang SB
    Curr Mol Med; 2016; 16(9):829-839. PubMed ID: 27889996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microsatellite alterations at selected tetranucleotide repeats are associated with morphologies of colorectal neoplasias.
    Lee SY; Chung H; Devaraj B; Iwaizumi M; Han HS; Hwang DY; Seong MK; Jung BH; Carethers JM
    Gastroenterology; 2010 Nov; 139(5):1519-25. PubMed ID: 20708618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mismatch repair status in the prediction of benefit from adjuvant fluorouracil chemotherapy in colorectal cancer.
    Jover R; Zapater P; Castells A; Llor X; Andreu M; Cubiella J; Piñol V; Xicola RM; Bujanda L; Reñé JM; Clofent J; Bessa X; Morillas JD; Nicolás-Pérez D; Payá A; Alenda C;
    Gut; 2006 Jun; 55(6):848-55. PubMed ID: 16299036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy of adjuvant chemotherapy with 5-fluorouracil in colorectal cancer depends on the mismatch repair status.
    Jover R; Zapater P; Castells A; Llor X; Andreu M; Cubiella J; Balaguer F; Sempere L; Xicola RM; Bujanda L; Reñé JM; Clofent J; Bessa X; Morillas JD; Nicolás-Pérez D; Pons E; Payá A; Alenda C;
    Eur J Cancer; 2009 Feb; 45(3):365-73. PubMed ID: 18722765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MSI-L/EMAST is a predictive biomarker for metastasis in colorectal cancer patients.
    Torshizi Esfahani A; Seyedna SY; Nazemalhosseini Mojarad E; Majd A; Asadzadeh Aghdaei H
    J Cell Physiol; 2019 Aug; 234(8):13128-13136. PubMed ID: 30549036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Impact of Mismatch Repair Status in Colorectal Cancer on the Decision to Treat With Adjuvant Chemotherapy: An Australian Population-Based Multicenter Study.
    He EY; Hawkins NJ; Mak G; Roncolato F; Goldstein D; Liauw W; Clingan P; Chin M; Ward RL
    Oncologist; 2016 May; 21(5):618-25. PubMed ID: 27009937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microsatellite instability is a favorable prognostic indicator in patients with colorectal cancer receiving chemotherapy.
    Hemminki A; Mecklin JP; Järvinen H; Aaltonen LA; Joensuu H
    Gastroenterology; 2000 Oct; 119(4):921-8. PubMed ID: 11040179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No evidence of EMAST in whole genome sequencing data from 248 colorectal cancers.
    Kondelin J; Martin S; Katainen R; Renkonen-Sinisalo L; Lepistö A; Koskensalo S; Böhm J; Mecklin JP; Cajuso T; Hänninen UA; Välimäki N; Ravantti J; Rajamäki K; Palin K; Aaltonen LA
    Genes Chromosomes Cancer; 2021 Jul; 60(7):463-473. PubMed ID: 33527622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microsatellite instability is a predictive marker for survival benefit from adjuvant chemotherapy in a population-based series of stage III colorectal carcinoma.
    Elsaleh H; Iacopetta B
    Clin Colorectal Cancer; 2001 Aug; 1(2):104-9. PubMed ID: 12445368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer.
    Ribic CM; Sargent DJ; Moore MJ; Thibodeau SN; French AJ; Goldberg RM; Hamilton SR; Laurent-Puig P; Gryfe R; Shepherd LE; Tu D; Redston M; Gallinger S
    N Engl J Med; 2003 Jul; 349(3):247-57. PubMed ID: 12867608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-Fluorouracil adjuvant chemotherapy does not increase survival in patients with CpG island methylator phenotype colorectal cancer.
    Jover R; Nguyen TP; Pérez-Carbonell L; Zapater P; Payá A; Alenda C; Rojas E; Cubiella J; Balaguer F; Morillas JD; Clofent J; Bujanda L; Reñé JM; Bessa X; Xicola RM; Nicolás-Pérez D; Castells A; Andreu M; Llor X; Boland CR; Goel A
    Gastroenterology; 2011 Apr; 140(4):1174-81. PubMed ID: 21185836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EMAST is a Form of Microsatellite Instability That is Initiated by Inflammation and Modulates Colorectal Cancer Progression.
    Carethers JM; Koi M; Tseng-Rogenski SS
    Genes (Basel); 2015 Mar; 6(2):185-205. PubMed ID: 25836926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FANCJ expression predicts the response to 5-fluorouracil-based chemotherapy in MLH1-proficient colorectal cancer.
    Nakanishi R; Kitao H; Fujinaka Y; Yamashita N; Iimori M; Tokunaga E; Yamashita N; Morita M; Kakeji Y; Maehara Y
    Ann Surg Oncol; 2012 Oct; 19(11):3627-35. PubMed ID: 22526901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microsatellite instability testing and its role in the management of colorectal cancer.
    Kawakami H; Zaanan A; Sinicrope FA
    Curr Treat Options Oncol; 2015 Jul; 16(7):30. PubMed ID: 26031544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biologic behavior of microsatellite-unstable colorectal cancer and treatment with 5-fluorouracil.
    Niv Y
    Isr Med Assoc J; 2005 Aug; 7(8):520-4. PubMed ID: 16106779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacogenetic studies on the prediction of efficacy and toxicity of fluoropyrimidine-based adjuvant therapy in colorectal cancer].
    Kralovánszky J; Adleff V; Hitre E; Pap E; Réti A; Komlósi V; Budai B
    Magy Onkol; 2007; 51(2):113-25. PubMed ID: 17660867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.